Modified Cardiac Rehab May Cut Mortality Risk for Stroke Survivors
As part of stroke recovery program, modified cardiac rehab may lower all-cause one-year mortality, improve overall and cardiovascular function.
As part of stroke recovery program, modified cardiac rehab may lower all-cause one-year mortality, improve overall and cardiovascular function.
A study compared patients with diffuse large B-cell lymphoma with a 1:10 cohort from the general population to determine the risk of cardiovascular events in patients receiving doxorubicin-containing regimens.
Incidence of myocarditis among young men estimated to be 6.43 and 11.25 per 100,000 vaccines in the week, two weeks after third dose.
Researchers sought to determine the incidence of fatal and nonfatal CVD during 5 years of follow up in adults with hemophilia.
Researchers analyzed the association between anemia and CV mortality, all-cause mortality, and major bleeding in patients with atrial fibrillation.
Researchers sought to determine whether adding daratumumab to carfilzomib would help prevent cardiovascular adverse events in patients with relapsed/refractory multiple myeloma.
Buerger disease typically affects young or middle aged male cigarette smokers.
Starting aspirin in patients 60 years or older to prevent a first heart attack or stroke is not recommended.
Researchers sought to determine whether clopidogrel would be more effective than aspirin monotherapy for patients with CAD.
Researchers sought to determine whether clopidogrel would be preferred over aspirin to reduce cardiovascular risk in patients with HIV.